
Complement component 3
ProteinWikipedia
26
MENTIONS
3
EPISODES
3
PODCASTS
Search complete. 26 mentions across 3 episodes found for "Complement component 3".
Oct 21, 2026
Episode 34: The Rationale for Complement Inhibition in the Management of IgA Nephropathy
D
2:47Dana RizkGUEST
Well, I think part of the surprise is the fact that when we check complement levels in the blood for these patients, we typically don't see any variance in the values.
D
2:56Dana RizkGUEST
We don't see low C3, low C4 like you would in a lupus patient.
D
3:00Dana RizkGUEST
Having said that, we shouldn't be as surprised.
D
3:02Dana RizkGUEST
If you biopsy a patient with IgA nephropathy, in about 90% of biopsy cases, you do see C3 deposited in the tissue.
D
3:11Dana RizkGUEST
Again, suggesting that there is complement activation and it's pretty obvious.
D
3:16Dana RizkGUEST
And we have a lot of data, even clinical data in humans that support the role of complement in IgA.
D
4:46Dana RizkGUEST
There's also serologic data that the complement system plays a role and is activated.
D
4:51Dana RizkGUEST
As I mentioned, the levels are typically normal.
Atypical Hemolytic Uremic Syndrome
S
2:15speaker_0HOST
Membrane cofactor protein, also called CD46, protects host cells by supporting factor I mediated complement regulation.
S
2:24speaker_0HOST
Complement factor B and complement factor C3 also play important roles in the activation and amplification cascade.
S
2:32speaker_0HOST
When complement regulation fails, the alternative pathway C3-convertease becomes excessively active.
S
2:39speaker_0HOST
This drives additional complement activation and ultimately increases formation of C5-convertease and the terminal complement complex C5B9, also known as the membrane attack complex.
S
2:52speaker_0HOST
Excessive terminal complement activation damages endothelial cells.
S
3:24speaker_0HOST
This explains the classic triad of HUS, microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury.
S
3:33speaker_0HOST
Genetics is important, but it is not the whole story.
S
3:37speaker_0HOST
Some patients have pathogenic variants involving complement factor H factor I, factor B, C3, or membrane cofactor protein.
Episode 317: Intrinsic renal disease (part 2)
S
23:26Shahryar KhanGUEST
I don't move forward until as I've got the report of the serum complements.
S
23:30Shahryar KhanGUEST
So C3 and C4.
S
23:32Shahryar KhanGUEST
C3 tells me whether alternative pathway is being active or not, and alternative pathway is usually kind of complement, uh, dysregulation, either, uh, in intrinsically or in the presence of an active infection or malignancy, which is kind of leading the cascade activity all the time.
S
23:48Shahryar KhanGUEST
And C3-- and the C4 is usually classical pathway, so that's kind of your classical antigen-antibody complexes like lupus, infections, uh, cryoglobulinemia.
S
23:57Shahryar KhanGUEST
These are the things considered when you have got a low C4.
S
24:00Shahryar KhanGUEST
If you've got both low C3 and C4, focus more on the classical pathway.
S
24:03Shahryar KhanGUEST
There's a third pathway, lectin pathway as well, which is used in the setting of chronic infection.
S
24:08Shahryar KhanGUEST
So if you've got low C3, there's a certain differential diagnosis.